Key Calls (Monday): Upgrades, Downgrades & Initiations

 

 

 

 


1580572w


 

(Bloomberg) — Changes since prior close.


UPGRADES:

Upgrade
* Access National (ANCX) upgraded to outperform at KBW; PT
$34
* Assembly Bio (ASMB) upgraded to buy at B Riley FBR; Price
Target $42
* BPY-U CN (BPY-U CN) upgraded to outperform at Evercore
ISI
* CenterPoint Energy (CNP) upgraded to outperform at Wells
Fargo; PT $30
* Conagra (CAG) upgraded to buy at UBS; PT Set to
$40
* GE (GE) upgraded to overweight at Barclays; Price Target
$16
* Kosmos Energy (KOS) upgraded to buy at Investec
* LMAT US (LMAT)
raised to outperform at Barrington Research; PT $34
* LeMaitre
Vascular (LMAT) upgraded to buy at Roth Capital; PT $34
* Malvern
Bancorp (MLVF) upgraded to buy at Sandler O’Neill; PT $24
* Movado
(MOV) upgraded to outperform at Cowen; Price Target $50
* On Deck
Capital (ONDK) upgraded to neutral at BTIG
* Petrobras ADRs (PETR4
BZ) upgraded to outperform at Bradesco BBI; PT $20
* Petrobras ADRs
(PETR4 BZ) upgraded to overweight at JPMorgan; PT $17
* Willis
Towers (WLTW) upgraded to outperform at Credit Suisse; PT $166


 DOWNGRADES:

Downgrade

* Beacon Roofing (BECN) downgraded to market perform at William
Blair
* Cogent Comms (CCOI) downgraded to neutral at BTIG
* Glu Mobile
(GLUU) downgraded to neutral at Roth Capital; PT $8
* Jeld-Wen
(JELD) downgraded to neutral at Baird; PT $23
* Kimberly-Clark
(KMB) downgraded to neutral at Goldman
* Taylor Morrison (TMHC)
downgraded to market perform at JMP
* Union Bankshares (UBSH)
downgraded to neutral at Compass Point; PT $41
* Waters (WAT)
downgraded to market perform at Leerink Partners; PT $190
* Whiting
Petroleum (WLL) downgraded to equal-weight at Capital One
* iRobot
(IRBT) downgraded to neutral at Piper Jaffray; Price Target $90


 INITIATIONS:
INITIATION
* Addus HomeCare (ADUS) rated new outperform at RBC; PT $81
* Braskem
ADRs (BRKM5 BZ) resumed at bofaml with Neutral; PT $32
* Cabot Corp
(CBT) rated new overweight at Barclays; PT $76
* Lantronix (LTRX)
rated new buy at Needham; PT $5.50
* Methanex (MX CN) rated new
equal-weight at Barclays
* NIO Inc. ADRs (NIO) rated new buy at
Deutsche Bank; PT $9.50

 


-R.W.N II, yours in 322.

cia

Banyan Capital Management, LLC (“BCM”) is a publisher, not a registered investment advisor, and nothing in BCM’s newsletter is intended, and it should not be construed, to be investment advice. BCM’s newsletter is for informational use only. Any mention in BCM’s newsletter of a particular security, index, derivative, or other instrument is neither a recommendation by BCM to buy, sell, or hold that security, index, derivative, or other instrument, nor does it constitute an opinion of BCM (or of any of its officers, employees, agents or representatives) as to the suitability of that security, index, derivative or other instrument for any particular purpose. BCM is not in the business of giving investment advice or advice regarding the suitability for any purpose of any security, index, derivative, other instrument or trading strategy and nothing in BCM’s newsletter should be so used or relied upon. BCM is not acting as your financial advisor nor in a fiduciary capacity, with regard to any securities, index, derivative or other instrument referred to in BCM’s newsletter. Also, no representation is made concerning the tax implications in any applicable jurisdiction regarding any securities, index, derivative or other instrument and BCM is not advising you in respect of the tax implications. All opinions and estimates in the newsletters are given as of the date of their publication on the BCM’s website and are subject to change and BCM does not assume any obligation to update the newsletters or to reference any such changes. BCM hereby expressly disclaims any and all representations and warranties that: (a) the content of its newsletters is correct, accurate, complete, reliable or a guaranty of future performance; (b) any of its newsletters will be available at any particular time or place, or in any particular medium; and (c) that any omission or error in any of its newsletters will be corrected. BCM shall not be liable for any errors or omissions made in its newsletters or for any inaccuracies in its assumptions. BCM specifically disclaims liability for any losses or damages (incidental, consequential or otherwise) that may arise from the newsletters and that are either used or relied upon by anyone for any reason, including without limitation, the use of the newsletters in the preparation of any financial books and records. Although from time to time BCM’s newsletter may link to or promote others’ websites or services, BCM is not responsible for and does not control those websites or services. BCM’s newsletter is published and distributed in accordance with applicable United States and foreign copyright and other laws. Without the prior written consent of BCM, no person or entity, directly or indirectly, may copy, reproduce, recompile, decompile, disassemble, reverse engineer, distribute, publish, display, perform, modify, upload to create derivative works from, transmit, or in any way exploit all or any part of BCM’s website, its newsletter, or any other material belonging to BCM.Without the prior written consent of BCM, no person or entity, directly or indirectly, may offer all or any part of BCM’s website, its newsletter, or any other material belonging to BCM for sale, nor may any person or entity, directly or indirectly, distribute all or any part of BCM’s website, its newsletter, or any other material belonging to BCM over or by means of any medium.Without the prior written consent of BCM, no person or entity, directly or indirectly, may make all or any part of BCM’s website, its newsletter, or any other material belonging to BCM, available as part of or in connection with another website, whether by hyperlink, framing on the Internet or otherwise. At any given time BCM’s principals may or may not have a financial interest in any or all of the securities and instruments discussed herein. At any given time BCM’s principals may or may not have a financial interest in any or all of the securities and instruments discussed herein.

Advertisements

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.